These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27570535)

  • 1. Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.
    Webber MJ; Anderson DG; Langer R
    Expert Rev Endocrinol Metab; 2015; 10(5):483-489. PubMed ID: 27570535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates.
    Chou DH; Webber MJ; Tang BC; Lin AB; Thapa LS; Deng D; Truong JV; Cortinas AB; Langer R; Anderson DG
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2401-6. PubMed ID: 25675515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologically Inspired and Chemically Derived Methods for Glucose-Responsive Insulin Therapy.
    VandenBerg MA; Webber MJ
    Adv Healthc Mater; 2019 Jun; 8(12):e1801466. PubMed ID: 30605265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia.
    Hanazaki K; Kitagawa H; Yatabe T; Munekage M; Dabanaka K; Takezaki Y; Tsukamoto Y; Asano T; Kinoshita Y; Namikawa T
    Am J Surg; 2014 Jun; 207(6):935-41. PubMed ID: 24480234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of automating insulin delivery for the treatment of type 1 diabetes.
    Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF
    Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically controlled closed-loop insulin delivery.
    Ravaine V; Ancla C; Catargi B
    J Control Release; 2008 Nov; 132(1):2-11. PubMed ID: 18782593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Closed-loop system in the management of diabetes: past, present, and future.
    Shah VN; Shoskes A; Tawfik B; Garg SK
    Diabetes Technol Ther; 2014 Aug; 16(8):477-90. PubMed ID: 25072271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term glycemic control with hepatic insulin gene therapy in streptozotocin-diabetic mice.
    Thulé PM; Campbell AG; Jia D; Lin Y; You S; Paveglio S; Olson DE; Kozlowski M
    J Gene Med; 2015; 17(8-9):141-52. PubMed ID: 26190010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy.
    Chen NK; Tan SY; Udolph G; Kon OL
    Gene Ther; 2010 May; 17(5):592-605. PubMed ID: 20182520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical blood glucose control in hyper- and hypoglycemic and exercise scenarios by means of an H(infinity) algorithm.
    Quiroz G; Femat R
    J Theor Biol; 2010 Mar; 263(1):154-60. PubMed ID: 19962391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-Dendrimer Nanocomplex for Multi-Day Glucose-Responsive Therapy in Mice and Swine.
    Xian S; Xiang Y; Liu D; Fan B; Mitrová K; Ollier RC; Su B; Alloosh MA; Jiráček J; Sturek M; Alloosh M; Webber MJ
    Adv Mater; 2024 Feb; 36(5):e2308965. PubMed ID: 37994248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
    Davis T; Salahi A; Welsh JB; Bailey TS
    Diabetes Obes Metab; 2015 Dec; 17(12):1126-32. PubMed ID: 26179879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.